US forces on Saturday stopped an oil tanker off the coast of Venezuela for the second time in less than two weeks, following President Donald Trump’s announcement of a blockade on sanctioned vessels.
After a long run of regulatory stumbles and the recent withdrawal of its lone commercial drug from the U.S. market, Intercept Pharmaceuticals is implementing a restructuring and rounds of job cuts in ...
GRAND JUNCTION, Colo. (KJCT) - On December 6, cadets at the Technical College of the Rockies (TCR) held the academy’s first-ever memorial run to honor Deputy Derek Geer, a graduate who served with the ...
New Delhi: Rumours of the former Pakistani Prime Minister’s death have been circulating for several days. Imran’s family has accused the Shehbaz Sharif-led government of isolating him for weeks. There ...
With AEW Full Gear 2025 right around the corner, AEW President and CEO Tony Khan has taken to X (formerly known as Twitter) to announce that a brand new champion will be crowned on November 22. Khan ...
Star Wars: Unlimited TCG debuted in March 2024 with a 252-card set called Spark of Rebellion. Asmodee has since released four more sets, and the next one, Secrets of Power, is slated for November 7.
Sir Sadiq Khan has urged the Government to pause the introduction of new visa rules that could result in between 200 and 300 Transport for London staff being deported. The mayor said many TfL staff, ...
Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...
Rohit Saraf is gearing up for Shashank Khaitan's 'Sunny Sanskari Ki Tulsi Kumari,' where he plays Vikram. Following the teaser release, viewers likened his entry to Shah Rukh Khan's iconic 'Kabhi ...
While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.
Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.